LifeMD, Inc.
LFMD
$4.28
-$0.11-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.12% | 41.47% | -8.52% | -4.89% | -1.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.12% | 41.47% | -8.52% | -4.89% | -1.22% |
| Cost of Revenue | 7.26% | 35.26% | 48.93% | 38.56% | 29.51% |
| Gross Profit | 40.21% | 42.47% | -15.11% | -10.27% | -5.33% |
| SG&A Expenses | 34.35% | 26.82% | -18.41% | -13.11% | -7.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.99% | 36.06% | 32.28% | 28.46% | 24.26% |
| Total Operating Expenses | 31.27% | 28.58% | -10.44% | -6.51% | -2.42% |
| Operating Income | 9.06% | 69.27% | 32.91% | 23.35% | 13.45% |
| Income Before Tax | 8.86% | 61.07% | 23.95% | 20.81% | 14.76% |
| Income Tax Expenses | -69.40% | -69.40% | -19.06% | 39.72% | 39.72% |
| Earnings from Continuing Operations | 10.85% | 61.28% | 23.79% | 19.51% | 13.65% |
| Earnings from Discontinued Operations | 955.01% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.66% | -130.59% | -113.99% | 28.93% | 58.39% |
| Net Income | 127.64% | 159.72% | 40.02% | 40.15% | 36.53% |
| EBIT | 9.06% | 69.27% | 32.91% | 23.35% | 13.45% |
| EBITDA | 17.69% | 75.81% | 30.67% | 20.02% | 9.23% |
| EPS Basic | 104.19% | 133.37% | 40.91% | 42.71% | 42.67% |
| Normalized Basic EPS | 24.26% | 62.29% | 27.87% | 30.81% | 33.66% |
| EPS Diluted | 103.82% | 132.78% | 40.46% | 42.24% | 41.98% |
| Normalized Diluted EPS | 24.26% | 62.29% | 27.87% | 30.81% | 33.66% |
| Average Basic Shares Outstanding | 10.16% | 10.22% | 9.80% | 12.53% | 17.23% |
| Average Diluted Shares Outstanding | 10.16% | 10.22% | 9.80% | 12.53% | 17.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 4.62% | 2.67% | -0.67% | -0.67% | -0.58% |